sorafenib has been researched along with cariporide in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (cariporide) | Trials (cariporide) | Recent Studies (post-2010) (cariporide) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 409 | 10 | 79 |
| Protein | Taxonomy | sorafenib (IC50) | cariporide (IC50) |
|---|---|---|---|
| Sodium/hydrogen exchanger 1 | Homo sapiens (human) | 1.0802 | |
| Sodium/hydrogen exchanger 1 | Oryctolagus cuniculus (rabbit) | 0.026 | |
| Sodium/hydrogen exchanger 1 | Rattus norvegicus (Norway rat) | 0.0589 | |
| Sodium/hydrogen exchanger 3 | Oryctolagus cuniculus (rabbit) | 0.026 | |
| Sodium/hydrogen exchanger 2 | Oryctolagus cuniculus (rabbit) | 0.026 | |
| Sodium/hydrogen exchanger 2 | Homo sapiens (human) | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mihaila, RG | 1 |
1 review(s) available for sorafenib and cariporide
| Article | Year |
|---|---|
A minireview on NHE1 inhibitors. A rediscovered hope in oncohematology.
Topics: Amiloride; Antineoplastic Agents; Apoptosis; Cation Transport Proteins; Cell Line, Tumor; DNA Damage; Drug Interactions; fms-Like Tyrosine Kinase 3; Genes, abl; Guanidines; Heme Oxygenase-1; Humans; Hydrogen-Ion Concentration; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Mutation; Niacinamide; Osmolar Concentration; Patents as Topic; Phenylurea Compounds; Protein Kinase Inhibitors; Signal Transduction; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Sorafenib; Sulfones; Tumor Hypoxia; Up-Regulation | 2015 |